Navigation Links
Sinexus Welcomes New CEO and Completes Series B
Date:6/5/2008

Sinexus Hires CEO, Lisa Earnhardt, and Adds PTV Sciences to Premier VC

Backers

PALO ALTO, Calif., June 5 /PRNewswire/ -- Sinexus, Inc. made two key announcements today: Lisa Earnhardt joined as President & CEO and PTV Sciences has teamed up with their premier VC backers in a $20 Million Series B financing. This financing round was led by PTV Sciences along with existing investors Kleiner Perkins Caufield & Byers and U.S. Venture Partners.

Earnhardt joined Sinexus in March 2008. Well-known for her leadership in the medical device industry, Lisa most recently was the President of Boston Scientific's Cardiac Surgery division. She played an instrumental role in the sale of that business to the Getinge Group in January 2008. Previously, she held a variety of sales and marketing positions within Guidant's Cardiac Rhythm Management and Cardiac Surgery divisions. Lisa has a B.S. in Industrial Engineering from Stanford University and an M.B.A. from Northwestern's Kellogg School of Management, where she serves on the Advisory Board.

PTV Sciences, based in Austin, Texas, is a leading life science venture capital firm. Joining the Board of Directors of Sinexus will be Evan Melrose, M.D. Managing Director of PTV Sciences.

"We are delighted that PTV Sciences and Dr. Melrose have joined with us to bring our innovative chronic sinusitis therapy to market," said Earnhardt. "Sinexus will benefit from PTV's domain expertise and passion for advancing patient care."

"Sinexus has assembled a strong team that is developing compelling solutions for Ear, Nose & Throat physicians and their patients. We look forward to joining the Sinexus team," added Dr. Melrose.

About Sinexus

Sinexus, Inc. (http://www.sinexusinc.com) is a development-stage medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize i
'/>"/>

SOURCE Sinexus, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Womens World Banking Welcomes New Network Member From Tunisia
2. MJGC Welcomes New Administrator-in-Training Shlomo Katz
3. MJGC Welcomes New Director of Social Work Alla Lerner
4. Patient Advocate Foundation Welcomes Leading Health Care Experts to Executive Board of Directors
5. Friends of WFP Welcomes World Hunger Relief Week
6. New York City Aesthetic Plastic Surgeon Welcomes top Skin Care Line into his Office
7. St. Pauls Senior Homes & Services Welcomes Some of San Diegos Neediest Displaced Seniors
8. HealthCoach Welcomes James Herrera as Vice President of Consulting
9. Delmarva Foundation Welcomes New Chief Operating Officer
10. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
11. Truthful Labeling Coalition Welcomes Perdue Farms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...epresentatives from the fitness,company Burn Mach... Shriners,Hospitals for Children in Chicago last ...nique, cause; The Burn Machine donated more than $...ent to the first ever Shriners,Wheelchair Bodybui...com/cgi-bin/prnh/20081203/CLW007 ) , "We k...
(Date:12/2/2008)...ersity, The Brigham and Women,s Hospital (Boston),...has found a new drug with the potential to allevia...k. , Dr Shantha Rajaratnam from Monash Universi...gical Medicine said tasimelteon, a drug which acts...ighly effective treatment for circadian rhythm sle...
(Date:12/2/2008)... Reminder, the nation,s leading,comprehensive pat... industry,technology today at Javits Center in Ne...ng and distributing video testimonials can be used... popular platforms such as YouTube, Google,Videos...with an effective,business strategy for increasin...
(Date:12/2/2008)... enterprise software and online services veteran i...scribers of Yugma,s instant web conferencing solut...RWEB) December 2, 2008 -- Yugma , the leading web... collaborate instantly using the Internet, announc...utive Officer. , , ,Vas has more than 20 years of ...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
...onmental Protection announced today that aerial sp...mosquito larvae in Philadelphia have been resched...oLex CG, which is not a chemical pesticide, but is...that targets mosquito and black fly larvae when ad...
...known as integrin alpha 7 (integrin 7) lead to unc...cer, report researchers at the University of Pitt...ed today in the Journal of the National Cancer Ins...a7 represents an important new target for cancer t...
...5N1 strain of bird flu has been detected among pou...n capital, officials said Wednesday. The virus w... Sungai Buloh area of Selangor state, said Kamarud...se control section at the Department of Veterinary...
...to stop feeling hungry, for researchers have devel...rmone which makes people feel full . Researchers d...aturally occurring hormone that is excreted during...he brain called MC4R. When the bodys need for food...
Other Medicine News:Health News:Rescheduled: Aerial Mosquito Treatment for Philadelphia 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 3Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 4Health News:Bird Flu Reappears in Malaysia 2
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...d intelligent clinical applications take workflow ... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall...thcare ) highlights the ACUSON S2000(TM) Automate...rst multi-use, automated volume breast ultrasound ... Meeting of the Radiological Society of North Amer...
(Date:11/25/2008)...nding statin use broadly in wake of AHA-presented ...wswire/ -- JUPITER, a clinical trial suggesting ro...althy patients with elevated CRP, should not promp...to a national poll directed at health professional... poll conducted by medical news site MedPage Today...
(Date:11/25/2008)...ssess Survival of Patients Receiving Litx versus S...ellular Carcinoma , , BELLEVUE, Wash., Nov....(LSO) today announced the completion of enrollment...ion Therapy(TM) (Litx(TM)) as a treatment for unre...n as hepatoma or primary liver cancer. , , ...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 1Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 2Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 3Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 4Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 1Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 2Signals from the Atlantic salmon highway 4508 1Signals from the Atlantic salmon highway 4508 2Signals from the Atlantic salmon highway 4508 3Signals from the Atlantic salmon highway 4508 4Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 1Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 2Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 3Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 4
... the Journal of Clinical Oncology -, NEW YORK, Jul...a,Phase II study - which will be published in the ...ncology (JCO) and are now,available as an Early Re...www.jco.org/">www.jco.org - demonstrate that,ixab...ional,compound, has activity in patients with meta...
... TMC125, an Investigational NNRTI,from Tibotec, YA...m two,ongoing Phase 3 studies (DUET-1 and DUET-2) ...h documented non-nucleoside reverse,transcriptase ...stance reached an undetectable viral load (defined...V-1 RNA copies/mL) with,TMC125 (etravirine), Tibot...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
The inventory system designed for Wholesale Distributors and centralized distribution centers for Optical chains.
...Ordering/Dispensing has gained recognition as the ... lens ordering system. It enables opticians to pla...g SDS electronic communications technology. When u...r 3D frame tracers, lens shapes are automatically ...
... is a complete practice and business management so...ts, opticians and ophthalmologists- It is designed...ally rich and intuitive windows interface with a f...- The multi-user version of this practice and Busi...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis.
Medicine Products: